Find Academic Supervisors

• Immunology
• Molecular Biology
• Systems Biology
• +2 more

Vanessa Hawlin M.Sc. is a researcher at the Institute of Animal Cell Technology and Systems Biology within the Department of Biotechnology and Food Science at the University of Natural Resources and Life Sciences, Vienna (BOKU). Based at Muthgasse 18 in Vienna, she maintains an active research profile with current contact information including email vanessa.hawlin@boku.ac.at and telephone +43 1 47654-79880. Her research focuses on immunological mechanisms at the molecular level, particularly examining antibody structures and their functional interactions. Her work bridges cellular biology with systems-level analysis to understand complex immune responses, with emphasis on protein structure-function relationships and molecular recognition processes in the immune system. Dr. Hawlin's recent scholarly contribution examines the structural and functional differences between hexameric and pentameric forms of immunoglobulin M (IgM) antibodies and their interactions with C1q components of the complement system. This 2024 publication in the journal Life represents cutting-edge research in molecular immunology with potential implications for understanding immune disorders and developing targeted therapies. While no supervised theses or doctoral students are currently listed in the institutional database, her active research status and recent publication indicate ongoing scholarly contributions to her field. The Institute of Animal Cell Technology and Systems Biology where she works represents BOKU's commitment to advanced cellular and molecular research with biotechnological applications.

• Fungal Biology
• Pathogenicity
• Host-pathogen interactions
• +7 more

Christophe D’Enfert is a Professor at Institut Pasteur and Head of the Fungal Biology and Pathogenicity Unit, which operates within the Mycology Department and the Department of Genomes and Genetics. His research focuses on the biology, pathogenicity, and genomics of Candida albicans and other pathogenic yeasts, with a strong emphasis on biofilm formation, morphogenesis, and host-microbiota interactions. He is affiliated with the National Institute for Agronomic Research (INRAE) and collaborates internationally, including with the University of Aberdeen. PhD in Molecular Biology, Institut Pasteur His research interests center on the mechanisms underlying fungal infections, particularly in immunocompromised individuals. He investigates C. albicans genomic diversity, colonization of biotic and abiotic surfaces, and regulation of morphogenesis. His lab uses functional genomics, high-throughput screening, and molecular biology to dissect virulence mechanisms and antifungal resistance. The recent publications reflect a strong trend in understanding fungal cell wall architecture, metabolic adaptation in biofilms, host-fungal-microbiota interplay, and genomic basis of virulence and resistance. His work spans molecular microbiology, systems biology, and translational medical mycology. Coordinator, Marie Sklodowska-Curie Initial Training Network (FunHoMic) Funded by Swiss National Science Foundation (Sinergia program) Christophe D’Enfert leads multiple research grants and mentors several PhD students and postdoctoral researchers. His lab is part of major transversal projects at Institut Pasteur, including INCEPTION, focused on integrative biology and data science. He contributes to educational initiatives such as the MOOC on Medical Mycology and specialized courses in molecular genetics and epigenetics. His team develops advanced genomic tools like the C. albicans ORFeome and barcoded strain collections, fostering collaborative research across Europe. He leads or co-leads multiple ongoing projects including FunHoMic, CANDIHUB, Candida genomic diversity, biofilm colonization, and morphogenesis regulation. His lab, located at 25-28 Rue du Docteur Roux in Paris, is equipped with state-of-the-art instrumentation for microbiology, genomics, and imaging, supporting a multidisciplinary approach to fungal pathogenesis.

Pierre BruhnsView profile

Professor

• Immunology
• Antibody Biology
• Autoimmunity
• +9 more

Pierre Bruhns is a Professor and Head of the Unit of Antibodies in Therapy and Pathology (INSERM UMR 1222) within the Department of Immunology at the Institut Pasteur in Paris, France. His research integrates fundamental, clinical, and industry-oriented approaches to understand the role of antibodies, Fc receptors, and the complement system in allergy, autoimmunity, and immunotherapy. His research interests center on the pathogenic and protective roles of human antibodies in diseases such as severe allergy, autoimmune disorders (including immune thrombocytopenic purpura and perioperative anaphylaxis), and infectious diseases. He employs humanized mouse models, droplet microfluidics for high-throughput plasma cell screening, and clinical studies (e.g., AUTOIMMUNI-B, NASA, WaspPenIP, ENDOPHEN) to investigate antibody effector functions, B cell responses post-vaccination (notably SARS-CoV-2), and to develop novel antibody-based therapies for allergic and autoimmune conditions. The recent trends in his publications highlight a strong focus on SARS-CoV-2 immunology, mechanisms of anaphylaxis, asthma prevention via cytokine-targeting vaccines, and the biology of plasma cells. His work increasingly leverages advanced technologies like microfluidics for immune monitoring and therapeutic development. Pierre Bruhns has supervised numerous PhD students and postdoctoral researchers, contributing significantly to training the next generation of immunologists. He has also secured research funding and leads projects with clinical and translational implications. He is actively involved in the scientific community, having organized major international conferences such as 'Antibodies as Drugs' (Keystone Symposia, 2022) and 'Antibodies and Complement' (2023), which bring together experts from academia and industry to discuss the latest advances in antibody and complement therapeutics. His laboratory, the Antibodies in Therapy and Pathology unit, functions as a hub for interdisciplinary research, combining molecular immunology, advanced technology development, and clinical investigation to elucidate disease mechanisms and pioneer new treatments.

Guillaume DumenilView profile

Professor

• Microbiology
• Host-pathogen interactions
• Vascular biology
• +7 more

Guillaume Dumenil is a Professor and Principal Investigator at the Pasteur Institute in Paris, France, where he leads the Pathogenesis of Vascular Infections Unit within the Cell biology and infection department. His research is funded by prestigious grants, including an ERC Advanced Grant (DESTOP) and a previous ERC Starting Grant. He is a leading expert on the pathogenesis of Neisseria meningitidis , the bacterium responsible for meningitis and septicemia. His research focuses on understanding how N. meningitidis colonizes human blood vessels, evades the innate immune system (particularly neutrophils), and causes vascular damage. His lab employs a highly multidisciplinary approach, integrating microbiology , cell biology , vascular biology , structural biology (using Cryo-EM and cross-linking mass spectrometry), and physics . Key to his research is the use of innovative models, such as a human skin xenograft model in mice and 3D microfluidics-based vessel-on-a-chip systems, to study infection in a physiologically relevant context. His recent publications (2021–2024) reveal detailed mechanisms of bacterial virulence, including the structural basis of type IV pili function and immune escape, the dynamics of bacterial adhesion under shear stress, and the identification of bacterial safe havens within arterioles. His work bridges fundamental science with therapeutic applications, aiming to develop new preventive and treatment strategies. His scientific achievements have been recognized with several major awards: ERC Advanced Grant (2022) Grand prix Fondation NRJ – Institut de France (2021) Pasteur Vallery Radot Prize (2019) ERC Starting Grant (2012) Professor Dumenil leads an active research group, mentoring numerous PhD students and post-doctoral fellows. His lab has secured significant grant funding, including multiple ongoing projects like DESTOP and PVMOC, and has produced influential research that is also communicated to the public through videos, media, and science festivals. The lab utilizes advanced technological platforms, including the Cytometry Platform and microfluidics, and is part of larger collaborative initiatives at the Pasteur Institute such as the Labex IBEID (Integrative Biology of Emerging Infectious Diseases).

Nunzia CaporarelloView profile

Assistant Professor

• Pulmonary Medicine
• Lung Injury and Repair
• Fibrosis
• +3 more

Nunzia Caporarello is an Assistant Professor in the Department of Medicine at Loyola University Chicago . She leads the CAP LAB, focusing on lung injury, repair, and fibrosis , particularly in Idiopathic Pulmonary Fibrosis (IPF). Ph.D. in Basic and Applied Biomedical Sciences, University of Catania, Italy Her research examines how the pulmonary vasculature promotes lung repair and how aging and disease disrupt this process. She employs mouse models for vascular responses and human lung samples for translational insights into disease progression, aiming to develop novel interventions for chronic lung diseases. The lab also investigates endothelial-derived signaling molecules (angiocrine factors) and circulating biomarkers in lung repair, with a focus on their dysregulation in aging and connective tissue diseases associated with fibrosis. Recent publications highlight her work on extracellular vesicles , ERG signaling , and redox-shifted fibroblasts in fibrosis contexts. Key collaborations include institutions like the Department of Veterans Affairs and cross-disciplinary teams in biomedical engineering and cell biology . Lab projects cover topics such as miRNA targeting in pulmonary fibrosis , complement-mediated vascular injury , and 3D vascular network assays . Her work bridges basic science with clinical applications in chronic respiratory diseases.

• Immunology
• Autoimmune Diseases
• Kidney Diseases
• +2 more

Prof. Dr. med. Christian Krebs is a Senior Lecturer at the III. Medical Clinic and Polyclinic within the University Medical Center Hamburg-Eppendorf (UKE). His research focuses on the heterogeneity and plasticity of renal T cells , particularly Th17 cells, and identifying novel therapeutic targets for autoimmune kidney diseases. He studied medicine in Göttingen and Hamburg, completed his habilitation in 2014, and trained at UKE. Key research areas: Immunology, Autoimmune Diseases, Kidney Pathophysiology His recent publications (2021–2025) highlight advancements in understanding T cell dynamics, complement signaling, and therapeutic interventions like ustekinumab. Articles span disciplines including immunology , nephrology , and single-cell transcriptomics , with subfields such as Th17 cell plasticity , cytotoxic T cell mechanisms , and γδ T cell roles in kidney inflammation . Scientific awards: Adalbert-Buding-Preis, Dr. Martini-Preis, Hans-U.-Zollinger-Forschungspreis He collaborates on projects like TH17 Cell Plasticity in Renal Autoimmune Diseases (A05) and contributes to clinical translation in kidney immunology. No student advisement or part-time roles are documented.

• Neurobiology
• Cognitive Sciences
• Neurodevelopmental Disorders
• +7 more

Lucas Pozzo-Miller is a Professor in the Department of Neurobiology at the University of Alabama at Birmingham (UAB), with additional affiliations in Cell, Developmental and Integrative Biology; Psychology; and Neurology. His research focuses on neurodevelopmental disorders, particularly Rett syndrome, autism spectrum disorders, and Alzheimer's disease, examining synaptic plasticity, neuronal circuitry, and molecular mechanisms. 1986-1989: Biology PhD from Universidad Nacional de Córdoba, Argentina 1990-1992: Postdoctoral training at Case Western Reserve University 1992-1995: Postdoctoral work at Roche Institute of Molecular Biology 1998-present: Faculty member at UAB His research examines: Methyl-CpG-binding protein 2 (MeCP2) dysfunction in Rett syndrome BDNF/TrkB signaling pathways and therapeutic development Corticostriatal and hippocampal-prefrontal circuit abnormalities Perineuronal net regulation of synaptic plasticity Microglial activation and neuroimmune interactions Epigenetic mechanisms and evolutionary conservation of MBD proteins Key publications demonstrate: Altered MBD protein interactions in neurodevelopment Deficits in social memory circuits through vHIP-mPFC projections Therapeutic potential of small-molecule TrkB ligands Dysregulation of synaptic plasticity in multiple neurodevelopmental models Major grants include funding from: National Institute of Neurological Disorders and Stroke (NINDS) National Institute on Drug Abuse (NIDA) International Rett Syndrome Foundation Rettsyndrome.org National Science Foundation (NSF) Yale University Teaching activities include: Co-chairing and mentoring multiple dissertation committees Instructing courses in developmental neuroscience and neuro student summer seminars Participating in MEDMAP peer teaching activities

Jonathan WorboysView profile

Research Fellow

• Immunology
• Cell biology
• Proteomics
• +4 more

Jonathan Worboys is a Wellcome Trust Research Fellow at the University of Manchester, affiliated with the Lydia Becker Institute of Immunology and Inflammation and the Division of Immunology, Immunity to Infection & Respiratory Medicine. He holds a PhD in Cancer Biology (2015) from the Institute of Cancer Research (University of London) and a BSc in Biology with a Year in Europe from Imperial College London (2010). PhD: Cancer Biology, Institute of Cancer Research (2015) BSc: Biology with a Year in Europe, Imperial College London (2010) His research investigates how spatial organization of immune receptors governs their function, focusing on immune checkpoints—proteins that regulate immune responses and are critical in cancer immunotherapy. Current therapies targeting these checkpoints lack refinement, and his work aims to improve their efficacy. His recent studies explore TIGIT receptor dynamics, NLRP3 inflammasome regulation, and super-resolution microscopy applications. He received the 2024 Research Staff Excellence Award and leads an 8-year Wellcome Trust-funded project on nanoscale immune checkpoint governance. Expertise spans immunology , cell biology , super-resolution microscopy , and mass spectrometry . His work contributes to SDG-related research in health and well-being through immune signaling advancements.

David FairlieView profile

Professor

• Chemistry
• Biochemistry
• Immunology
• +8 more

Professor David Fairlie is a renowned academic at the University of Queensland, serving as the Centre Director of the Institute for Molecular Bioscience and an Affiliate Professor in the School of Chemistry and Molecular Biosciences. His roles include leadership in the ARC Centre of Excellence for Innovations in Peptide and Protein Science. Previously, he held positions such as NHMRC Senior Principal Research Fellow and ARC Federation Fellow. Education includes postdoctoral studies at Stanford University and University of Toronto, postgraduate studies at Australian National University and University of New South Wales, and undergraduate studies at University of Adelaide. Research focuses on interdisciplinary science at the intersection of chemistry, biochemistry, immunology, and pharmacology. Key interests include drug design targeting inflammatory diseases, cancers, metabolic disorders, and neurodegenerative conditions. His group specializes in developing compounds that modulate enzymes, protein interactions, and cellular receptors. Publications highlight advancements in HDAC inhibitors, MAIT cell biology, and peptide-based therapies. Awards include NHMRC and ARC fellowships, and recognition as a Highly Cited Researcher. Grants and funding span drug discovery, imaging technologies, and collaborations with pharmaceutical partners. Supervision of over 50 PhD and Master’s students underscores his mentorship in medicinal chemistry, biochemistry, and pharmacology. Active leadership in research centers and industry partnerships drives translational research towards clinical applications.

Ian HendersonView profile

Professor

• Microbiology
• Bacterial Pathogenesis
• Antimicrobial Resistance
• +5 more

Professor Ian Henderson is an Affiliate Professor at the School of Chemistry and Molecular Biosciences, University of Queensland (UQ), and Director of the Institute for Molecular Bioscience. He holds roles in the Centre for Superbug Solutions and the Office of the Provost. His research focuses on bacterial pathogenesis, protein secretion systems, antimicrobial resistance, and vaccine development, with interdisciplinary interests in plant and Drosophila genetics. He completed his BSc (Hons) at University College Dublin and PhD at Trinity College Dublin. Research Interests: His work spans microbiology, bacterial virulence mechanisms, and the genetic basis of pathogenesis. Notable areas include Salmonella pathogenesis, centromere dynamics in plants and Drosophila, and the development of novel vaccines targeting Gram-negative bacteria. His studies also address antibiotic resistance and antibody-mediated immune responses. Articles & Themes: Recent work highlights Salmonella-induced thrombosis mechanisms, centromeric satellite repeat evolution in Drosophila, and structural variation in Arabidopsis. He explores vaccine candidates for Klebsiella pneumoniae and investigates plasmid-driven antibiotic resistance adaptation. His research bridges immunology, genomics, and molecular biology to combat infectious diseases. Grants & Teams: Funded by ARC grants for antimicrobial resistance solutions and marine biodiscovery. Collaborates across institutions, including Trinity College Dublin and the University of Birmingham. Supervises PhD students in antibiotic resistance, bacterial genetics, and vaccine development.

Martin StoermerView profile

Research Fellow

• Medicinal Chemistry
• Organic Chemistry
• Virology
• +3 more

Dr Martin Stoermer is an Adjunct Research Fellow at the Institute for Molecular Bioscience (IMB), University of Queensland. He specializes in medicinal and organic chemistry, focusing on viral proteases from Flaviviruses (e.g., Dengue, West Nile) and Coronaviruses (e.g., SARS-CoV-2). His research combines chemical synthesis and molecular modeling to design inhibitors targeting these viruses. Since 2012, he has been on extended medical leave but continues research as an Adjunct. Education: Studied organic chemistry at the University of Sydney, joined UQ in 1993, worked at Bayer in Germany (1996), and returned to UQ in 2000 to join the Fairlie lab. Key roles include developing antiviral inhibitors, protease structure elucidation, and peptide drug design. Research interests include viral protease inhibition, molecular modeling, and drug discovery. His work spans Flaviviruses, Coronaviruses, and HIV protease inhibitors. Recent studies focus on SARS-CoV-2 proteases and homology modeling. Publications emphasize viral protease structures, inhibitor development, and cyclic peptides. He has contributed to grants for equipment like NMR spectrometers and computational platforms. Supervised PhD students in protease inhibitor projects. Labs: Works within the Fairlie Group at IMB, leveraging advanced facilities for NMR, mass spectrometry, and computational modeling.

Jürgen StrasserView profile

Researcher

• Immunology
• Biophysics
• Molecular Biology
• +3 more

Jürgen Strasser is a Researcher at the University of Applied Sciences Linz, affiliated with the Linz Center of Excellence's Medical Engineering department. His work focuses on understanding antibody-mediated immune responses, particularly IgG oligomerization and complement activation mechanisms. He contributes to interdisciplinary projects like ImageHeadstart (Industry 4.0 applications) and IgGMedCompAct (determining IgG-mediated complement activation determinants). Education: BSc, DI Dr. techn. (Doctor of Technical Sciences) Key Research Areas: Immunology, Biophysics, Complement System Biology Techniques: Atomic Force Microscopy, Biophysical Characterization Recent research emphasizes the interplay between antibody structure and immune effector functions, with publications in Small Science , Proceedings of the National Academy of Sciences , and EMBO Journal . He actively participates in international conferences such as IUPAB Congress and EMBO Workshops. Collaborations span institutions in Austria and Czech Republic, focusing on antibody engineering and medical imaging advancements. His work has been cited over 300 times, reflecting significant contributions to immunology and biophysics.

Johannes PreinerView profile

Lecturer

• Biophysics
• Molecular Dynamics
• Immunology
• +3 more

Johannes Preiner is a University Lecturer at the Johannes Kepler University Linz (since 2014), affiliated with the NASAN - Nano Structuring and Bio-Analytics research group within the Linz Center of Excellence for Medical Engineering. His work focuses on molecular dynamics at membrane interfaces, leveraging advanced atomic force microscopy (AFM) techniques. He holds a Habilitation in Biophysics (2023) and a PhD in AFM-based biophysics (2008), with a Technical Physics background (2005). Key research interests include antibody-mediated immune activation mechanisms, complement pathway dynamics, and membrane protein interactions. Notable collaborations include projects with GENMAB and Prof. Suzan Rooijakkers, yielding insights into IgG oligomerization-driven complement activation. Recent funded projects include IgGMedCompAct (2021–2024) and FcRClu (2020–2025). He has received the Macke-Scholarship and contributed to over 70 publications, including high-impact work on antibody dynamics and complement activation. His presentations span international venues, emphasizing multivalent interactions in immune responses.

Fabien PinaudView profile

Associate Professor

• Cell biology
• Membrane biophysics
• Mechanobiology
• +6 more

Fabien Pinaud is Associate Professor of Biological Sciences, Chemistry, and Physics & Astronomy at the University of Southern California , where he leads the Single Molecule Biophotonics Group . His laboratory develops and applies advanced optical imaging and nanomaterial tools to dissect how nanoscale membrane organization controls protein dynamics and cellular signaling in health and muscular-dystrophy-related disease. Education & Career Ph.D. (field not explicitly stated) Post-doctoral training (institutions not specified) Promoted to Associate Professor at USC in March 2019 Research Interests Dr. Pinaud’s work resides at the intersection of cell biology , membrane biophysics , mechanobiology , and nanomaterial science . His group uses single-molecule fluorescence microscopy , super-resolution imaging , and plasmonic nanoprobes to: Quantify how emerin and LINC-complex proteins organize the nuclear envelope under mechanical stress. Uncover nanoscale defects in voltage-gated calcium channels in C. elegans models of Duchenne muscular dystrophy. Design activatable SERS and photoacoustic nanoprobes for cancer diagnostics. Elucidate the scaffolding function of caveolin-1 membrane microdomains during mechanotransduction. Recent Publications & Trends Over the past decade the lab has produced >60 peer-reviewed articles, with the most recent work (2022–2025) focusing on emerin nanodomain self-assembly, SUN1/LINC complex mechanics, and in vivo single-molecule phenotyping of muscular dystrophy in living animals. A consistent theme is the integration of cutting-edge imaging with quantitative biophysical modeling to link molecular-scale behaviors to cellular and organismal function. Scientific Awards & Honors National Science Foundation – NSF-ANR Research Cooperation grants (DynamoLINC & MechaLINC) National Institutes of Health – R01 and R21 grants from NIAMS and NINDS NSF Division of Materials Research award for hybrid Raman nanoprobes Ming Hsieh Institute for Engineering Medicine grant for cancer research Faculty Member, F1000Prime Cell Biology – Membranes and Sorting Section Journal cover features in Nature Communications , Life Science Alliance , Journal of Biological Chemistry , Traffic , and others Training & Mentorship The Pinaud lab currently mentors graduate students Dai Zhai , Liying Wu , and Yunke Zhao , and hosts undergraduate researchers through USC’s BUGS and NSF-funded TRAINS programs. Since 2012, the group has trained >30 undergraduate, >15 high-school, and numerous rotating and visiting students, producing multiple award-winning theses and conference presentations. Laboratory & Resources The Single Molecule Biophotonics Group is housed in Ray Irani Hall 204A on the USC University Park campus. The facility is equipped with custom-built single-molecule fluorescence, super-resolution (PALM/STORM), TIRF, HILO, and SERS imaging systems, complemented by cell-culture and nanomaterial chemistry suites.

Ed TateView profile

Professor

• Chemical Biology
• Chemical Proteomics
• Medicinal and Biomolecular Chemistry
• +5 more

Ed Tate is a Professor and GSK Chair in Chemical Biology at Imperial College London's Department of Chemistry, part of the Faculty of Natural Sciences. He also holds a Satellite Group Leader position at the Francis Crick Institute. His research bridges organic chemistry, life sciences, and medicine, focusing on chemical biology and proteomics to understand disease mechanisms. He has pioneered methods for protein manipulation and drug discovery, including work on CD59 inhibitors and N-myristoyltransferase (NMT) inhibitors for malaria and cancer. Education: B.Sc. in Chemistry (University of Durham), Ph.D. in Organic Chemistry (University of Cambridge) under Prof. Steve Ley. Postdoctoral training included radical chemistry at École Polytechnique and molecular microbiology at the Pasteur Institute. Career progression: Senior Lecturer (2010), Reader (2012), Professor (2014), GSK Chair (2023). Research interests include chemical proteomics, targeted protein degradation, drug development, and understanding post-translational modifications like ADP-ribosylation and S-palmitoylation. His lab has spun out Myricx Bio, a biotech company developing antibody-drug conjugates. Awards include the 2020 RSC Corday-Morgan Prize, 2019 Sir David Cooksey Translation Prize, and multiple fellowships. Grants include funding from UK research councils, charities, and industry partnerships. Labs/Teams: Tate Group at Imperial and Francis Crick Institute, leading the Centre for Drug Discovery Science. Active in editorial roles for journals like Cell Chemical Biology and advisory roles for biopharma companies.